Tandem Diabetes Care (NSDQ:TNDM) shares soared after hours today on fourth-quarter results that topped the consensus forecast. Shares of TNDM were up 12.9% at $103.04 per share after the market closed. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.8%. Get the full story at our sister site, […]
Wall Street Beat
LivaNova slides despite Street-beating Q4
LivaNova (NSDQ:LIVN) shares took a dip this morning despite fourth-quarter results that topped the consensus forecast. The London-based company posted losses of $279.8 million, or -$5.75 per share, on sales of $269.6 million for the three months ended Dec. 31, 2020, for a 95.4% bottom-line slide deeper into the red on a sales decline of -6.3%. […]
Insulet rises on Street-beating Q4 revenues
Insulet (NSDQ:PODD) shares rose before the market opened today on fourth-quarter results that beat the consensus revenue forecast. The Acton, Mass.-based wearable insulin delivery system developer posted losses of -$17.1 million, or -26¢ per share, on sales of $246.1 million for the three months ended Dec. 31, 2020, for a bottom-line slide into the red on […]
Penumbra beats The Street in Q4 results
Penumbra (NYSE:PEN) posted fourth-quarter results that beat the consensus forecast on Wall Street. The Alameda, Calif.-based company reported profits of $2.6 million, or 10¢ per share, on sales of $166.9 million for the three months ended Dec. 31, 2020, for a bottom-line loss of 071.7% sales growth of 14.89% compared with Q4 2019. Adjusted to exclude […]
Owens & Minor soars on Street-beating Q4 results
Owens & Minor (NYSE:OMI) posted fourth-quarter results that beat the consensus forecast on Wall Street. The Mechanicsville, Va.-based company reported profits of $50.7 million, or 72¢ per share on sales of $2.4 billion for the three months ended Dec. 31, 2020, for a sales growth of 7.8% compared with Q4 2019. Adjusted to exclude one-time items, […]
Masimo reports a Street-beating Q4
Masimo (NSDQ:MASI) posted fourth-quarter results today that beat the consensus forecast on Wall Street, issuing 2021 guidance that also exceeds analysts’ expectations. The Irvine, Calif.–based maker of noninvasive patient monitoring technologies and sensors reported profits of $70.7 million, or $1.21 per share, on sales of $295.1 million for the three months ended Jan. 2, 2021, boosting […]
Titan Medical dips on Q4 losses
Titan Medical (TSX:TMD;OTC:TITFX) shares took a hit today on fourth-quarter losses that topped -$20 million. The Toronto-based company posted losses of -$20.6 million, for the three months ended Dec. 31, 2020, for a bottom-line slide into the red after posting profits of $2.4 million in the fourth quarter of 2019. Titan Medical attributed the results to […]
BREAKING: TransEnterix announces name change, new category of surgery
TransEnterix (NYSE:TRXC) announced today that it will change its name to Asensus Surgical and introduce a new category of surgery to its offerings. Research Triangle Park, N.C.-based Asensus Surgical said in a news release that its name change represents its broader vision of shaping the future of surgery by integrating computer vision and machine learning with […]
Medtronic rises on Street-beating Q3
Medtronic (NYSE:MDT) shares ticked up when the market opened today on third-quarter results that topped the consensus forecast. The Fridley, Minn.-based medtech giant posted profits of $1.3 billion, or 94¢ per share, on sales of $7.8 billion for the three months ended Jan. 29, 2021, for a -33.4% bottom-line slide on sales growth of 0.8%. Adjusted […]
Conformis soars on news of FDA clearance
Conformis (NSDQ:CFMS) recently received FDA 510(k) clearance for its ITotal Identity cruciate-retaining knee replacement system. According to a report from SeekingAlpha, Billerica, Mass.-based Conformis received 510(k) clearance for the ITotal Identity posterior-stabilizing knee replacement system along with the cruciate-retaining knee replacement system. The knee replacements have customized fitting properties with specificity for each patient receiving one. […]
PavMed to spin off subsidiary Lucid Diagnostics
Pavmed (NSDQ:PAVM) announced today that its majority-owned subsidiary Lucid Diagnostics will spin off into a separate public company. In a news release, Pavmed said Lucid Diagnostics intends to spin off if favorable market conditions continue to hold, whether it be through an initial public offering (IPO) or a business combination with a healthcare special purpose acquisition corporation. […]
